RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by RVL Pharmaceuticals plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for RVL Pharmaceuticals plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Harsaul Foundation | 10% Owner | 4,941,101Indirect | Oct 23, 2023 | 0 |
| Altchem Ltd | 10% Owner | 4,941,101 | Oct 23, 2023 | 0 |
| Orbit Co-Invest A-1 LLC | 10% Owner | 4,941,101 | Oct 23, 2023 | 0 |
| Avista Healthcare Partners, L.P. | 10% Owner | 0Indirect | Aug 17, 2023 | 0 |
| Avista Healthcare Partners GP, Ltd. | 10% Owner | 0Indirect | Aug 17, 2023 | 0 |
| Lask Alisa | Director | 112,557 | Aug 14, 2023 | 0 |
| Cowan Gregory L | Director | 90,055 | Jul 11, 2023 | 0 |
| DeBiasi Michael J. | Director | 40,000 | Jul 11, 2023 | 0 |
| Schaub James | EVP and COO | 524,835 | May 22, 2023 | 0 |
| Klein Christopher | General Counsel & Secretary | 180,573 | May 22, 2023 | 0 |
| Avista Capital Partners III GP, L.P. | 10% Owner | 0Indirect | Jan 30, 2023 | 0 |
| Orbit Co-Invest III LLC | 10% Owner | 0Indirect | Jan 30, 2023 | 0 |
| Burgstahler David F | Director, 10% Owner | 0Indirect | Jan 30, 2023 | 0 |
| Venkataraman Sriram | Director, 10% Owner | 0Indirect | Jan 30, 2023 | 0 |
| Markison Brian A | Chief Executive Officer | 2,976,020 | Aug 9, 2022 | 0 |
| deVries Tina Marie | EVP, Research & Development | 136,141 | May 20, 2022 | 0 |
| Einhorn Andrew J. | Chief Financial Officer | 141,473 | Jan 26, 2022 | 0 |
| Weiss Fred G | Director | 118,466 | Sep 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2023 (view filing)4:23 PM ET | Oct 19-20 | 4 days | Harsaul Foundation10% Owner | SSale | −14.1M | $0.0411 | −$580.1K | −74.1%4.94M after | 2 lotsDuplicate filing |
| Oct 23, 2023 (view filing)1:06 PM ET | Oct 19-20 | 4 days | Altchem Ltd and 1 other10% Owner | SSale | −14.1M | $0.0411 | −$580.1K | −74.1%4.94M after | 2 lots |
| Oct 20, 2023 (view filing)3:59 PM ET | Oct 18 | 2 days | Harsaul Foundation10% Owner | SSale | −3.42M | $0.0646 | −$221.0K | −15.2%19.1M after | Duplicate filing |
| Oct 20, 2023 (view filing)1:36 PM ET | Oct 18 | 2 days | Altchem Ltd and 1 other10% Owner | SSale | −3.42M | $0.0646 | −$221.0K | −15.2%19.1M after | |
| Aug 9, 2022 (view filing)5:18 PM ET | Aug 8 | 1 day | Avista Capital Partners III GP, L.P. and 3 others10% Owner | PPurchase | +8.00M | $1.55 | +$12.4M | +50.9%23.7M after | Duplicate filing |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Schaub JamesEVP and COO | PPurchase | +150.0K | $1.55 | +$232.5K | +38.5%540.0K after | |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Markison Brian AChief Executive Officer | PPurchase | +850.0K | $1.55 | +$1.32M | +40.0%2.98M after | |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Burgstahler David FDirector, 10% Owner | PPurchase | +8.00M | $1.55 | +$12.4M | +50.9%23.7M after | Duplicate filing |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Venkataraman SriramDirector, 10% Owner | PPurchase | +8.00M | $1.55 | +$12.4M | +50.9%23.7M after | |
| Dec 20, 2021 (view filing) | Dec 16 | 4 days | Schaub JamesEVP and COO | PPurchase | +93.8K | $1.07 | +$100.4K | +30.1%405.9K after |